What is the recommended treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, choosing the most convenient or least expensive option such as polymyxin B/trimethoprim, erythromycin, or gentamicin. 1, 2

Treatment Algorithm Based on Severity

Mild Bacterial Conjunctivitis

  • Prescribe any broad-spectrum topical antibiotic for 5-7 days, as no clinical evidence demonstrates superiority of one agent over another in uncomplicated cases. 1
  • Recommended options include:
    • Polymyxin B/trimethoprim 1
    • Erythromycin 1
    • Gentamicin 1
    • Tobramycin 1, 2
    • Tetracycline 1
  • This accelerates clinical and microbiological remission by days 2-5, reduces transmissibility, and allows earlier return to school/work. 1
  • Alternative: Povidone-iodine 1.25% ophthalmic solution may be equally effective when antibiotic access is limited. 1, 2

Moderate to Severe Bacterial Conjunctivitis

  • Reserve fluoroquinolones (moxifloxacin 0.5%, gatifloxacin 0.5%, ofloxacin 0.3%, or ciprofloxacin) for cases with copious purulent discharge, pain, and marked inflammation. 1, 3
  • Obtain conjunctival cultures and Gram staining before initiating treatment to guide therapy. 1, 2, 3
  • Fluoroquinolones provide broad-spectrum coverage against Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas. 3
  • Gatifloxacin dosing: Instill one drop every 2 hours while awake (up to 8 times) on Day 1, then one drop 2-4 times daily on Days 2-7. 4

Contact Lens Wearers

  • Always prescribe fluoroquinolones for contact lens wearers due to higher risk of Pseudomonas infection. 1, 3
  • Advise patients not to wear contact lenses during treatment. 4

Special Pathogen Considerations

Gonococcal Conjunctivitis

  • Systemic antibiotic therapy is mandatory; topical antibiotics alone are insufficient. 1, 2, 3
  • Add saline lavage to promote comfort and faster resolution of inflammation. 1
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal infections. 1
  • Requires daily follow-up until complete resolution. 3

Chlamydial Conjunctivitis

  • Systemic antibiotic therapy is required (oral azithromycin single dose or tetracycline for 7 days in adults); topical therapy alone is inadequate. 1, 2, 3
  • For neonates: Erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days. 1
  • In children with chlamydial or gonococcal conjunctivitis, consider the possibility of sexual abuse. 1, 2

MRSA Conjunctivitis

  • MRSA has been isolated with increasing frequency and may require compounded topical vancomycin based on culture results. 1, 3
  • Approximately 42% of staphylococcal isolates show methicillin resistance with high concurrent fluoroquinolone resistance. 3

Follow-Up Protocol

  • Advise patients to return if no improvement occurs after 3-4 days of treatment. 1, 2, 3
  • Follow-up should include visual acuity measurement and slit-lamp biomicroscopy. 1, 2
  • If severe inflammation persists, a brief course of topical corticosteroids may be indicated with baseline and periodic intraocular pressure monitoring. 1

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for viral conjunctivitis, which accounts for unnecessary costs and promotes resistance. 1
  • Avoid topical corticosteroids unless under close ophthalmologic supervision, as they may prolong bacterial shedding and worsen infection. 2, 3
  • Poor adherence to frequent administration regimens contributes to treatment failure. 1
  • Bacterial resistance is a growing concern, particularly with MRSA and fluoroquinolone-resistant organisms. 1, 2, 3

When to Refer to Ophthalmology Immediately

  • Visual loss or decreased visual acuity 1, 2, 3
  • Moderate or severe pain 1, 2
  • Severe purulent discharge 1, 2
  • Corneal involvement (infiltrate, ulceration, opacity, or scarring) 1, 2, 3
  • Lack of response to therapy after 3-4 days 1, 2
  • Recurrent episodes 1, 2
  • Neonatal conjunctivitis (requires prompt consultation and possible hospitalization) 1, 2

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Severe Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.